Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET Imaging.
PET/computed tomography (CT) imaging has gained a prominent role in the diagnosis and staging of malignancies. In lymphoma the role of PET/CT imaging continues to evolve as the understanding of its use in prognostication and response assessment improves. Currently, many groups are studying the potential function of PET/CT imaging in helping to direct management decisions for treating clinicians. This article summarizes the most up-to-date literature surrounding the topic of PET/CT-adaptive treatment of different lymphoma subjects. Although more studies are necessary to solidify the role of PET/CT, it is clear that this imaging modality holds much promise for the development of response-adaptive treatment algorithms in the future.
Department of Medicine, Hospital of the University of Pennsylvania, 100 Centrex, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Emily C
EC
Ayers
Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, 4283, Philadelphia, PA 19104, USA.
Sara
S
Fardin
Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, 4283, Philadelphia, PA 19104, USA.
Saeid
S
Gholami
Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, 4283, Philadelphia, PA 19104, USA.
Abass
A
Alavi
Department of Hematology/Oncology, Perelman Center for Advanced Medicine, West Pavilion, 2nd Floor, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA. Electronic address: anthony.mato@uphs.upenn.edu.
Anthony R
AR
Mato
D019788:Fluorodeoxyglucose F18; D006801:Humans; D008223:Lymphoma / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000379:methods*; D057285:Precision Medicine / Q000379:methods*; D019275:Radiopharmaceuticals
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
Lymphoma; PET imaging; PET-directed therapy; Response-adaptive treatment